GlassScriptPhysician profile
Jenna M Rickenbaugh
NPI 1841809696
$6,626.01
in general payments reported to CMS, 2019-2025
41 companies · $1,563 in 2025
The $1,563 reported for 2025 was more than what 91% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,371 · 2022: $883 · 2023: $1,555 · 2024: $1,254 · 2025: $1,563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,372.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,116.21 | 2021-2025 | |
| Novo Nordisk INC | $847.26 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $399.36 | 2021-2025 | Shingrix, Arexvy, Bexsero |
| Lilly USA, LLC | $399.35 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $382.92 | 2023-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $268.44 | 2023-2025 | Rexulti |
| Axsome Therapeutics, INC. | $268.06 | 2022-2025 | Auvelity |
| Pfizer INC. | $208.87 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $195.71 | 2021-2025 | Xifaxan, Trulance |
| Biohaven Pharmaceutical Holding Company LTD. | $188.99 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $182.73 | 2021 | |
| Merck Sharp & Dohme LLC | $131.99 | 2021-2024 | Verquvo, Vaxelis, Gardasil 9 |
| Astrazeneca Pharmaceuticals LP | $102.84 | 2021-2025 | Airsupra |
| Amgen INC. | $95.57 | 2021-2022 | |
| Astellas Pharma US INC | $84.37 | 2021-2024 | Veozah |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $83.32 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Nestle Healthcare Nutrition INC. | $68.93 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $56.68 | 2023-2025 | Gemtesa |
| Takeda Pharmaceuticals U.S.A., INC. | $48.90 | 2021-2023 | Trintellix |
| Lundbeck LLC | $42.84 | 2023-2024 | Vyepti |
| Bayer Healthcare Pharmaceuticals INC. | $41.69 | 2021-2024 | |
| Phathom Pharmaceuticals, INC. | $36.35 | 2024-2025 | Voquezna |
| Mylan Specialty L.P. | $34.45 | 2021 | |
| Inari Medical, INC. | $26.99 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Janssen Pharmaceuticals, INC | $25.06 | 2021-2022 | |
| Corium, LLC | $24.76 | 2023-2025 | Azstarys |
| Sunovion Pharmaceuticals INC. | $24.51 | 2021 | |
| Sanofi Pasteur INC. | $23.29 | 2022 | |
| Inspire Medical Systems, INC. | $23.06 | 2023 | Inspire |
| Allergan, INC. | $21.10 | 2021 | |
| Sanofi-Aventis U.S. LLC | $20.30 | 2021 | |
| Hologic Sales and Service, LLC | $17.98 | 2024 | Aptima |
| Lifescan, INC. | $17.44 | 2023 | |
| Amneal Pharmaceuticals LLC | $16.46 | 2021 | |
| Pulmonx Corporation | $15.84 | 2023 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Harmony Biosciences LLC | $15.71 | 2023 | Wakix |
| Pacira Pharmaceuticals Incorporated | $14.88 | 2024 | Exparel |
| Eisai INC. | $14.64 | 2021 | |
| Dexcom, INC. | $14.12 | 2025 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.24 | 2021 | |
| Novartis Pharmaceuticals Corporation | $11.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Rickenbaugh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.